Obesity Management Demands Much More than Medication
October 10, 2024

Obesity is a complex disease that requires a multispecialty approach to address the physical and also the mental and emotional components of the widespread disorder.

The Potential Harms of Breast Cancer Screening Need to be Explored and this Biostatistician is All In
October 10, 2024

The most common harm associated with breast cancer screening is a false positive finding; this UC Davis expert wanted to know more about how women respond.

COVID-19 Linked to Long-Term Risk of MACE, Especially Among Adults with non-O Blood Types
October 09, 2024

Prior SARS-CoV-2 infection was associated with a 2-fold increased risk for MACE for up to 3 years, even among people with no history of CVD, in a new analysis of UK Biobank data.

Ensifentrine, Novel PDE3, PDE4 Inhibitor, Improves Lung Function, QoL Regardless of COPD Severity
October 09, 2024

The combined bronchodilator/anti-inflammatory agent significantly improved lung function, symptoms and QoL in adults with moderate or severe airflow obstruction.

New Data for Arexvy Show Vaccine Efficacy Through 3 RSV Seasons in Older Adults
October 09, 2024

Data on adults aged 60 years and older who received a single dose of the RSV vaccine indicate safety and reactogenicity consistent with the overall GSK phase 3 trial program.

Preconception Prediabetes in Young Women and Adverse Birth Outcomes: Daily Dose
October 09, 2024

Your daily dose of the clinical news you may have missed.

FDA Black-Box Warnings on Antidepressants Linked to Reduced Treatment, Increased Risk of Suicide Among Youth
October 08, 2024

The FDA warnings were intended to increase physician monitoring for suicidal thoughts and behaviors but have had dramatic unintended consequences.

Survodutide Wins FDA Breakthrough Therapy Designation for Noncirrhotic MASH Treatment in Adults
October 08, 2024

The safety and efficacy of survodutide in patients with MASH and fibrosis will be assessed in a global pair of phase 3 trials.

FDA Grants Marketing Authorization to First OTC Flu/COVID-19 Test Outside Emergency Use Declaration
October 08, 2024

The non-prescription test has more than 95% sensitivity and specificity for SARS-COV-2 and influenza A and B and delivers results in approximately 15 minutes.

FDA Approves First-Ever Biologic Medicine for COPD: Daily Dose
October 08, 2024

Your daily dose of the clinical news you may have missed.